Conference Coverage (ASCO)
Polyvalent Melanoma Cell Vaccine Induces Humoral and Cell-Mediated Responses
Published in Immunotherapy Weekly, June 22nd, 1998
Researchers from the John Wayne Cancer Institute, California, conducted a phase II trial of PMCV in stage IV melanoma patients. Eddy C. Hsueh represented colleagues and reported the trial findings at the 34th Annual Meeting of the American Society of Clinical Oncology, held May 16-19, 1998, in Los Angeles, California (abstract "Correlation of Specific Immune Responses with Survival in AJCC Stage IV Melanoma Patients Receiving Polyvalent Melanoma Cell Vaccine").
"We hypothesized a correlation...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
Source: Immunotherapy Weekly (1998-06-22)
More Articles from Immunotherapy Weekly
- Conference Coverage (ASCO)
Fucosyl-GM1 Ganglioside Vaccine Is Immunogenic in SCLC Patients - Conference Coverage (ASCO)
Immunotoxin Therapy Prolongs Survival in AML Model - Conference Coverage (ASCO)
PROSTVAC Progresses to Phase II Trials In Battle against Prostate Cancer - AIDS Pathogenesis
Ho's "Raging Fire" Put Out - HSV-1
Chemokine Has Key Role in Virus-Induced Eye Inflammation - Immunology
New Tests Demonstrate Much Larger, More Specific Immune Responses to Viruses - More from this issue of Immunotherapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
